PL447283A1 - Lacticaseibacillus rhamnosus strain of lactic acid bacteria - Google Patents

Lacticaseibacillus rhamnosus strain of lactic acid bacteria

Info

Publication number
PL447283A1
PL447283A1 PL447283A PL44728323A PL447283A1 PL 447283 A1 PL447283 A1 PL 447283A1 PL 447283 A PL447283 A PL 447283A PL 44728323 A PL44728323 A PL 44728323A PL 447283 A1 PL447283 A1 PL 447283A1
Authority
PL
Poland
Prior art keywords
lactic acid
acid bacteria
lacticaseibacillus
rhamnosus strain
polish
Prior art date
Application number
PL447283A
Other languages
Polish (pl)
Other versions
PL248110B1 (en
Inventor
Katarzyna Śliżewska
Original Assignee
Politechnika Łódzka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Łódzka filed Critical Politechnika Łódzka
Priority to PL447283A priority Critical patent/PL248110B1/en
Publication of PL447283A1 publication Critical patent/PL447283A1/en
Publication of PL248110B1 publication Critical patent/PL248110B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest nowy szczep bakterii mlekowych Lacticasei bacillus rhamnosus ŁOCK 1151 zdeponowany w Polskiej Kolekcji Mikroorganizmów w Instytucie Immunologii i Terapii Doświadczalnej Polskiej Akademii Nauk im. Ludwika Hirszfelda we Wrocławiu pod numerem B/00501, wykazujący jednocześnie właściwości funkcjonalne, probiotyczne i przemysłowe.The subject of the application is a new strain of lactic acid bacteria Lacticasei bacillus rhamnosus ŁOCK 1151 deposited in the Polish Collection of Microorganisms at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław under number B/00501, demonstrating functional, probiotic and industrial properties.

PL447283A 2023-12-27 2023-12-27 Lacticaseibacillus rhamnosus strain of lactic acid bacteria PL248110B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL447283A PL248110B1 (en) 2023-12-27 2023-12-27 Lacticaseibacillus rhamnosus strain of lactic acid bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL447283A PL248110B1 (en) 2023-12-27 2023-12-27 Lacticaseibacillus rhamnosus strain of lactic acid bacteria

Publications (2)

Publication Number Publication Date
PL447283A1 true PL447283A1 (en) 2025-06-30
PL248110B1 PL248110B1 (en) 2025-10-20

Family

ID=96171615

Family Applications (1)

Application Number Title Priority Date Filing Date
PL447283A PL248110B1 (en) 2023-12-27 2023-12-27 Lacticaseibacillus rhamnosus strain of lactic acid bacteria

Country Status (1)

Country Link
PL (1) PL248110B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2407532A2 (en) * 2009-03-10 2012-01-18 Hero España, S.A. Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
CN111820283A (en) * 2020-06-19 2020-10-27 石家庄君乐宝乳业有限公司 Anti-constipation infant formula milk powder and preparation method thereof
KR102294456B1 (en) * 2021-02-17 2021-08-27 주식회사 메디오젠 Infant and child origin lactic acid bacteria Lactobacillus rhamnosus MG4502 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
CN114717131A (en) * 2021-09-07 2022-07-08 青岛蔚蓝生物股份有限公司 Lactobacillus rhamnosus with protective effect on skin injury and application thereof
CN116376770A (en) * 2023-04-04 2023-07-04 仁仁微生物科技研究(沈阳)有限公司 Application of lactobacillus rhamnosus RH0121 in preparation of hypoglycemic products

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2407532A2 (en) * 2009-03-10 2012-01-18 Hero España, S.A. Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
CN111820283A (en) * 2020-06-19 2020-10-27 石家庄君乐宝乳业有限公司 Anti-constipation infant formula milk powder and preparation method thereof
KR102294456B1 (en) * 2021-02-17 2021-08-27 주식회사 메디오젠 Infant and child origin lactic acid bacteria Lactobacillus rhamnosus MG4502 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
CN114717131A (en) * 2021-09-07 2022-07-08 青岛蔚蓝生物股份有限公司 Lactobacillus rhamnosus with protective effect on skin injury and application thereof
CN116376770A (en) * 2023-04-04 2023-07-04 仁仁微生物科技研究(沈阳)有限公司 Application of lactobacillus rhamnosus RH0121 in preparation of hypoglycemic products

Also Published As

Publication number Publication date
PL248110B1 (en) 2025-10-20

Similar Documents

Publication Publication Date Title
Cao et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases
Forsythe et al. Immunomodulation by commensal and probiotic bacteria
Mohamadzadeh et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
Fung et al. Lymphoid-tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism
US20200306323A1 (en) New use for treatment of clostridium difficile infections
DK1436380T3 (en) Composition comprising a lactobacillus strain and uses thereof
ES2524432T3 (en) Lactic acid bacteria such as probiotic strains and compositions containing the same
Duary et al. Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells
Scully et al. Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+ CD25+ T cell numbers
SE9702083L (en) Pharmaceutical preparation for controlling pathogenic intestinal bacteria
Wang et al. Lactobacillus casei regulates differentiation of Th17/Treg cells to reduce intestinal inflammation in mice
NZ789320A (en) New application of bifidobacterium lactis bl-99 in inhibiting intestinal inflammation
PL447283A1 (en) Lacticaseibacillus rhamnosus strain of lactic acid bacteria
PL430619A1 (en) Strain of lactic bacteria Lactobacillus rhamnosus
PL442281A1 (en) Lactobacillus plantarum PL8 strain and its use
Lopez Cazorla et al. Evaluation of Lactobacillus paracasei subsp. tolerans isolated from Jenyn's sprat (Ramnogaster arcuata) as probiotic for juvenile rainbow trout Oncorhynchus mykiss (Walbaum, 1792)
PL441131A1 (en) Strains of lactic acid bacteria of the genus Lactiplantibacillus plantarum, a composition containing them and its application for the fermentation of plant products
FR3123804B1 (en) Probiotic and its uses
PL447717A1 (en) Bacterial strain Agrobacterium sp. Azo12
PL422593A1 (en) Lactic bacterial strain of Lactobacillus reuteri
PL415947A1 (en) New bacterial strain of Lactobacillus plantarum PL4
PL444444A1 (en) Bacterial strain Agrobacterium sp. Azo12
Kim et al. Gut microbiota-mediated immunomodulatory effects of Lactobacillus rhamnosus HDB1258 cultured in the lava seawater in the colitis mouse model
Midhun et al. Probiotic application of beneficial bacteria for improved health and disease control
PL450244A1 (en) Substrate for the production of a composition containing siderophores